Presentation by Medisafe CEO, Omri Shor, Oct 19, 2021, for the mHealth Israel community.
- Medisafe’s Patient Engagement Platform
- Real World Evidence: Economic Impact for Pharma
- Connecting Pharma to patients
- Case Study: Supporting Patients through Digital Platform
-
At Medisafe it is our mission to empower people to improve their health using technology. A mission a decade stronger as we’ve been supporting patients in their daily lives since our company was founded in 2012. Our digital solutions have a Real Impact for Real patients (like Makeba and her son, 2 real Medisafe users).
Our success in making medication management a part of daily life, has made us a leading digital therapeutics company specializing in digital drug companions. We create solutions that put hyper-personalized, and holistic, support in the palms of patients’ hands.
We accomplish this type of support with our interoperable platform. Let me tell you a bit more about Medisafe’s Next-Gen digital platform
Medisafe currently has 8 million registered users, worldwide, who rely on us to manage all their medications. This includes patient and caregivers who have found us on their own, and program users, who are enrolled in branded digital patient support. <CLICK>
Of our monthly active users, 68% of them are use Medisafe daily. We see more engagement among users with their daily medication management than popular social media platforms such as Facebook, twitter or Instagram. <CLICK>
We take a holistic approach to medication management to create empowerment and engagement. The average Medisafe user is managing six or more medications. We put proactive and positive support in their hands. <CLICK>
We take this a step further with our pharma partners . Our proven digital solutions show an average adherence lift of 15—20% over existing patient support resources and programs.
We make all of this patient engagement possible with Medisafe’s digital drug companions. Our advanced platform helps patients navigate their treatment journeys through personalized, timely support, keeping them digitally connected throughout the treatment journey.
Our innovations and technologies together leverage a keen understanding of the patient mindset and predict how intervene to reach treatment goals.
Medisafe’s JITI™ technology increases patient engagement, improves medication adherence and extends treatment retention through predictive AI delivering personalized patient support at precise moments in each patient journey. It is an AI engine fueled by therapeutic elements, patient support, and patient elements.
Medisafe’s Care Integration Engine incorporates data from digital companions into existing patient support models. This scalable innovation can be seamlessly folded into existing solutions and deployed as part of the Care Connector solution to offer patient support teams insights into daily patient behaviors.
Medisafe Maestro is our advance technology that activates optimal digital patient journeys with personalized timely support. Medisafe Maestro designs, deploys and manages digital drug companions to support patients on specific treatment, and enables scalable solutions.
Through an advanced digital platform, we’re able to bring the digital patient journey to life and incorporate existing solutions and services seamlessly in a personalized digital experience.
As we look at Real-World Evidence of the use of digital drug companions, many of questions we get from our pharma partners is: what’s the value of these programs?
To answer this question we worked with Sage Growth Partners, Healthcare Research consultants, to create an Economic Impact Model to demonstrate value delivered to pharmaco through Medisafe platform.
Below is the analysis modeled for a biologic which identifies potential value capture over the next two years.
Model focuses on impact through following use cases:
Improve First Fill Rate (increase in the number of patients “taking” first dose/injection with Medisafe through improved onboarding processes)
Improved Adherence (increasing the percentage of compliant patients to their scheduled injections)
Extension of Persistence (extending the duration of compliant patients on therapy)
Care Coordination Efficiency (adding digital channel to patient support improves quality of support and improves productivity of clinicians (connection rate, time spent on critical activities))
Expanded Referrals
Improved Clinical Outcomes
Each of these use cases is a lever to deliver value by comparing existing practices without Medisafe to value delivered through Medisafe platform.
As we look at Real-World Evidence of the use of digital drug companions, another important area of focus in on connecting pharma to patients.
In 2020 an established Pharma Hub, seeking to augment their existing patient support model, partnered with Medisafe to provide nurses with a digital patient engagement platform.
By incorporating Medisafe’s digital solutions into the nurse and patient support tools both the Hub and the Pharma Brand experienced immediate and impressive program results.
Patient support nurses incorporated the Care Connector and digital drug companion into patient onboarding calls. Nurses offered patients a digital tool to manage all of their medications and help them stay connected to a clinical support team. <CLICK>
Hub nurses easily adapted existing patient support workflow to incorporate onboarding patients into the Medisafe platform, with great success. Of the patients offered digital support 45% enrolled in the program. <CLICK>
Patients weren’t the only ones to benefit from Medisafe digital solutions. Incorporating the Care Connector into their workflow, nurses gained great efficiency, and increased bandwidth to directly support the patients whose care they manage. Comparing digitally aided patient support to control group shows increased efficiency through every phase of the patient journey. <CLICK>
Real World Evidence isn’t just about providing value to pharma, but also about improving the lives of patients. To prove that digital drug companions improve patient lives, Medisafe commissioned Komodo Health, healthcare data and analytics firm, to conduct study on a biologic digital drug companion program to validate outcomes through Rx claims.
Adherence and Persistence: Komodo Health conducted two sets of analysis comparing Medisafe users in the biologic digital drug companion program to a matching control set based off demographic, relevant diagnosis (Dx) and treatment (Rx) criteria. The only difference between the Medisafe test group and control group is the use of the digital drug companion. In the analysis, the Medisafe test group improved adherence by 6-7% and extended refills by 5.25 weeks (15%).
Access and Coordination: Results from one digital program around access and coordination showed significant impact on Access and Coordination. This case study includes a Medisafe designed and integrated program that provides transparency to patients through prior auth period to first injection support. Not only did first fill increase by 5% but overall therapy compliance and extension on therapy improved delivering a two-year value to pharmaco close to $30M.
Care Coordination Efficiencies: This case study focuses on a integrated program in which patient support incorporated Medisafe’s digital solutions to manage all of their medications and help them stay connected to their support team.
To better understand the true impact on patients, we also capture feedback directly from patients on how patients are managing their health and using digital tools to manage their lives.
Medisafe routinely surveys its patient population on current health issues, and can track changes in perceptions over time. This provides real-world insights into the lives of patients and what issues may be impacting their health.
For example, in our most recent survey regarding current COVID-19 issues, we found:
A majority of patients have become vaccinated compared to just the 6% who intended to receive the vaccine in Jan.
A majority of patients intend to get a booster shot compared to the 20% who ever intended to get the vaccine
Vaccine efforts have helped to improve patients’ perception of pharma companies - improved 11% in just one year
We also find nuances in patient surveys that show variances in attitudes among men, women, and communities of color and ethnicity
These insights help to create a communication loop with patients, and obtain valuable information to help tailor support messages and provide guidance throughout the treatment journey.
But perhaps the best way to capture real-world feedback from patients is to take their word for it.
Medisafe is available to both Android and iOS smartphone users, and we maintain a 4.7 out of 5 star rating.
More than 400,000 user reviews show that more patients turn to Medisafe to help manage their medications and support their treatment journey.
This real-world evidence shows that patients want a convenient, simple, and personalized approach to their medication journey, and Medisafe is meeting that need.